试论安定性不合格消石灰对柔性路面质量的影响

由于过烧石灰的存在和消解不当等原因，造成消石灰安定性不合格，当石灰稳定类路面结构成型或投入使用后，消石灰中的生石灰颗粒开始吸收周围水分，慢慢消解，消解过程中发生体积膨胀，对路面产生破坏。解决石灰安定性问题对防止公路前修后坏，延长路面使用寿命具有积极的现实意义。     

新型清洁压裂液的实验室合成

研制出一种新型的双子季铵盐表面活性剂———N,N-双十八烷基-N,N,N,N-四醇乙基-二溴乙二铵(Gemini-OHAB),对用Gemini-OHAB及其它辅剂配制的新型压裂液体系性能进行了研究。结果表明:该体系具有良好的粘弹性、悬砂性能、低温溶解性以及抗温稳定性能;而且由于双子季铵盐表面活性剂中引入了醇乙基,该新型压裂液体系解决了传统季铵盐类清洁压裂液体系的低温不溶性及高生物毒性,也克服了甜菜碱类清洁压裂液体系抗温性能低的缺点,具有良好的市场应用前景。     

web设计中div＋css页面布局的应用研究

随着web标准化设计理念的普及,目前网站几乎均采用DIV＋CSS进行网页的排版布局,用DIV布局,使用CSS层叠样式来实现页面的外观。本文就DIV布局时CSS样式表一些关键属性设置进行探讨。     

CC430F5137的低功耗无线数据采集节点设计

随着无线传感器网络的发展,无线网络数据采集节点的低功耗要求也不断提高。针对这一要求,利用内部集成了射频模块的CC430F5137设计并实现了一种低功耗无线数据采集节点。利用无线模块唤醒功能降低了系统功耗,同时根据载波监听功能改进了射频发送函数,提高了抗干扰能力。实验结果表明,该设计的低功耗和抗干扰方法是可行的。     

河湖淤泥絮凝沉降特性试验研究

絮凝沉降性能是河湖疏浚淤泥资源化处理中重要且未完善的研究课题。以武汉沙湖、官桥湖及南湖3种淤泥为研究对象,通过沉降筒试验,利用清浑交界面沉降速度和上清液浊度研究了粒径分布、初始含沙量及高分子聚合物对河湖淤泥絮凝沉降特性的影响规律,并探讨了沉降筒尺寸对试验结果的影响。试验结果表明:河湖淤泥粒径越小,淤泥絮凝沉降越慢,上清液浊度越小;随初始含沙量的增加,河湖淤泥整体沉降速度变小,但当初始含沙量增加到一定值后,初始含沙量的影响作用开始变弱;高分子聚合物会促进河湖淤泥絮凝沉降;沉降筒尺寸虽然对试验结果略有影响,但对于分析河湖淤泥絮凝沉降特性无较大影响。研究河湖淤泥絮凝沉降特性对于河湖通航、蓄洪、水质修复、疏浚淤泥的处理均有重要意义。     

复杂偏压小净距隧道围岩压力计算及参数影响性研究

为研究不同隧道净距及地表坡度对复杂偏压浅埋小净距隧道围岩压力的影响规律,引用公路隧道设计规范,建立围岩压力计算模型,推导出隧道围岩压力的理论计算公式;结合数值模拟验证了理论计算公式的合理性,讨论了不同隧道净距和不同地表坡度的参数值变化对先行洞和后行洞的拱顶、拱腰及拱脚围岩压力的影响规律。结果表明:在两洞先后开挖情况下,隧道净距及地表坡度的变化对隧道内侧围岩压力影响较大,并且先行洞内侧围岩压力同净距及坡度大小正相关,后行洞内侧围岩压力同净距及坡度大小负相关。研究结果可为类似隧道工程的设计和施工提供参考。     

清晰数的比较

在清晰数的四则运算的基础上,给出了清晰数心的概念,继而定义了清晰数的大小关系,这样就可以进行清晰数的比较,为以后的研究奠定了基础。     

H_3PW_6Mo_6O_(40)·nH_2O催化过氧化氢清洁氧化环己酮合成己二酸

以自制H3PW6Mo6O40.nH2O为催化剂,在无有机溶剂、相转移催化剂的情况下,用过氧化氢氧化环己酮合成己二酸。探讨了催化剂用量、过氧化氢用量、反应时间、反应温度对反应的影响。确定了最佳反应条件为n(环己酮)∶(n磷钼钨杂多酸)∶(n过氧化氢)=100∶0.15∶400,在90℃反应5h,己二酸的分离收率达75.8%。     

金堆城钼细泥过滤脱水应用研究

对在“57钼精矿”生产过程中产生的用常规过滤无法进行脱水的钼细泥，用TT系列陶瓷过滤机进行脱水研究。完全解决了钼细泥的脱水问题。保证了“57钼精矿”生产工艺的畅通。     

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets

This study was carried out to quantitate the expression levels of microRNA-17, -19a, -34a, -155, and -210 (miRs) expressed in nine clear cell renal cell carcinoma (ccRCC) and one chromophobe renal cell carcinoma cell line with and without sarcomatoid differentiation, and in six primary kidney tumors with matching normal kidney tissues. The data in the five non-sarcomatoid ccRCC cell lines—RC2, CAKI-1, 786-0, RCC4, and RCC4/VHL—and in the four ccRCC with sarcomatoid differentiation—RCJ41T1, RCJ41T2, RCJ41M, and UOK-127—indicated that miR-17 and -19a were expressed at lower levels relative to miR-34a, -155, and -210. Compared with RPTEC normal epithelial cells, miR-34a, miR-155, and miR-210 were expressed at higher levels, independent of the sarcomatoid differentiation status and hypoxia-inducible factors 1α and 2α (HIFs) isoform expression. In the one chromophobe renal cell carcinoma cell line, namely, UOK-276 with sarcomatoid differentiation, and expressing tumor suppressor gene TP53, miR-34a, which is a tumor suppressor gene, was expressed at higher levels than miR-210, -155, -17, and -19a. The pilot results generated in six tumor biopsies with matching normal kidney tissues indicated that while the expression of miR-17 and -19a were similar to the normal tissue expression profile, miR-210, -155, -and 34a were expressed at a higher level. To confirm that differences in the expression levels of the five miRs in the six tumor biopsies were statistically significant, the acquisition of a larger sample size is required. Data previously generated in ccRCC cell lines demonstrating that miR-210, miR-155, and HIFs are druggable targets using a defined dose and schedule of selenium-containing molecules support the concept that simultaneous and concurrent downregulation of miR-210, miR-155, and HIFs, which regulate target genes associated with increased tumor angiogenesis and drug resistance, may offer the potential for the development of a novel mechanism-based strategy for the treatment of patients with advanced ccRCC.